BioNanoTech
Hillsborough
About BioNanoTech
At BioNanoTech, we are on a mission to save lives. We have solved a significant hurdle for drug innovation & discovery. Our revolutionary size-invariant, ultra-high purity, and high-yield protein and antibody purification technology platform unlocks the $265B market. We create new drug and vaccine discovery pathways, manufacturing at a fraction of the previous lifetime costs. Our technology enables biopharma to expand their current production and revisit previous low-yield lines at the production scale, identifying new opportunities and turning waste into revenue so that no cure is left behind.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $340.0K
- Last round: Grant (Oct 2024)
- Website: bionanotech.co
- Phone: [email protected]
Industries & Categories
B2B, Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bionanotech-145342 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.